← Open Payments lookup

ULLA LAAKSO: Open Payments

NPI 1598841371 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$181,632 in 547 payments from 20 companies in 2025. Trend: 2023 $172,345 · 2024 $168,227 · 2025 $181,632

Speaker / faculty: $106,568Honoraria: $26,850Travel & lodging: $20,803Consulting: $14,398Food & beverage: $12,902Education: $111
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.74$49,071
Alkermes, Inc.55$28,440
Otsuka America Pharmaceutical, Inc.31$19,811
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$19,802
E.R. Squibb & Sons, L.L.C.63$19,480
Axsome Therapeutics, Inc.41$14,552
Supernus Pharmaceuticals, Inc.21$11,572
ABBVIE INC.40$8,269
Tris Pharma Inc44$7,682
Lundbeck LLC47$897

Products named: FANAPT, LYBALVI, CAPLYTA, COBENFY, Auvelity, ABILIFY MAINTENA, Qelbree, VRAYLAR.

Industry payments across NY — which companies pay providers there.